Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,784 total articles

ONEOK Declares Quarterly Dividend

ONEOK Declares Quarterly Dividend

ONEOK, Inc., a leading midstream energy infrastructure company, announced its board of directors declared a quarterly dividend of $1.07 per share, unchanged from the previous quarter, with an annualized dividend of $4.28 per share. The dividend will be payable on May 15, 2026, to shareholders of record as of May 4, 2026. The company reaffirmed its …

Mawson Infrastructure Group Inc. Becomes Big Digital Energy, Inc.; Receives Nasdaq Listing Determination; Already in Compliance, To Request Hearing

Mawson Infrastructure Group Inc. Becomes Big Digital Energy, Inc.; Receives Nasdaq Listing Determination; Already in Compliance, To Request Hearing

Mawson Infrastructure Group Inc. has officially changed its name to Big Digital Energy, Inc. and will begin trading on Nasdaq under ticker BGDE starting April 30, 2026. The company focuses on carbon-free powered digital infrastructure supporting AI, HPC, and digital assets like Bitcoin mining. It recently received a Nasdaq delist determination due …

Credicorp Ltd.: Credicorp’s “1Q26 quiet period”

Credicorp Ltd.: Credicorp’s “1Q26 quiet period”

Credicorp Ltd., a leading financial services holding company in Peru with presence across Latin America and the US, is entering its quiet period starting April 30, 2026, until May 14, 2026, during which it will not disclose or comment on financial results in preparation for the Q1 2026 earnings release.

Chemed Reports First-Quarter 2026 Results

Chemed Reports First-Quarter 2026 Results

Chemed Corporation reported its Q1 2026 financial results with consolidated revenue increasing 1.6% to $657.5 million. The hospice care segment, VITAS, saw revenue growth of 3.1% and improved operational metrics, while the Roto-Rooter plumbing segment faced slight revenue declines. Encouraged by stronger-than-expected VITAS performance and signific…

Rocket Lab Unveils New High-Performance Star Tracker Optimized for Accuracy in Increased Radiation Environments

Rocket Lab Unveils New High-Performance Star Tracker Optimized for Accuracy in Increased Radiation Environments

Rocket Lab announced its new High-Performance Star Tracker (ST-HP), engineered to deliver better than 1 arcsecond pointing accuracy and enhanced radiation tolerance for spacecraft operating in low Earth orbit and beyond. This innovation leverages Rocket Lab's extensive experience and in-house manufacturing to provide a cost-effective, scalable solu…

AVITA Medical to Announce First Quarter 2026 Financial Results

AVITA Medical to Announce First Quarter 2026 Financial Results

AVITA Medical, a therapeutic acute wound care company, announced it will release its first quarter 2026 financial results on May 14, 2026. The company will hold a conference call and webcast to discuss the results and recent business developments. AVITA Medical is known for its RECELL technology used in the treatment of burns and trauma wounds, wit…

Century Aluminum resumes production at Grundartangi ahead of schedule

Century Aluminum resumes production at Grundartangi ahead of schedule

Century Aluminum Company resumed production on the second potline of its Grundartangi smelter in Iceland several months ahead of schedule. This potline comprises about two-thirds of the plant's capacity. Repairs to transformers were successfully completed, enabling the accelerated restart, with near full production expected by the end of July. Perm…

Financial Institutions, Inc. Reports Net Income Available to Common Shareholders of $20.6 million, or $1.04 per Diluted Share, for the First Quarter of 2026

Financial Institutions, Inc. Reports Net Income Available to Common Shareholders of $20.6 million, or $1.04 per Diluted Share, for the First Quarter of 2026

Financial Institutions, Inc. (NASDAQ: FISI) reported a robust financial performance in Q1 2026, delivering net income available to common shareholders of $20.6 million or $1.04 per diluted share, representing a significant year-over-year increase. The company demonstrated a healthy net interest margin expansion, loan growth driven by commercial len…

Burke & Herbert Financial Services Corp. Announces First Quarter 2026 Results and Declares Common Stock Dividend

Burke & Herbert Financial Services Corp. Announces First Quarter 2026 Results and Declares Common Stock Dividend

Burke & Herbert Financial Services Corp. announced its first quarter 2026 financial results showing strong earnings growth, solid asset quality, and a healthy capital position. The Company declared a quarterly dividend of $0.55 per share and highlighted the pending merger with LINKBANK, which is expected to close on May 1, 2026. Key financial metri…

Orchid Island Capital Announces First Quarter 2026 Results

Orchid Island Capital Announces First Quarter 2026 Results

Orchid Island Capital, Inc., a REIT specializing in Agency RMBS investments, announced a net loss of $20.0 million for Q1 2026 due to widened mortgage spreads triggered by geopolitical tensions following a Middle East war onset. Despite higher net interest income and maintaining a strong liquidity position, the company faced significant unrealized …

Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

Absci Corporation, a clinical-stage biopharmaceutical company utilizing generative AI in drug discovery, will report its first quarter 2026 financial and operating results on May 7, 2026, with a webcast conference call to discuss business developments and outlook. The company is advancing its therapeutic pipeline including ABS-201, targeting androg…

AppFolio, Inc. Announces First Quarter 2026 Financial Results

AppFolio, Inc. Announces First Quarter 2026 Financial Results

AppFolio, Inc. announced robust first quarter 2026 financial results, reporting a 20% year-over-year revenue increase to $262 million and a 50% rise in GAAP operating income to $51 million. The company highlighted growth in units under management and continued AI integration to boost customer value and operational efficiency. AppFolio also raised i…

Digital Realty Reports First Quarter 2026 Results

Digital Realty Reports First Quarter 2026 Results

Digital Realty, the world's largest cloud- and carrier-neutral data center platform, reported robust first quarter 2026 results highlighted by significant increases in net income, funds from operations per share, and record new bookings, particularly in hyperscale AI-related leasing. The company also raised its 2026 Core FFO per share guidance, ref…

iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule

iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule

iTonic Holdings Ltd announced that Nasdaq approved an additional 180-day extension until October 19, 2026, for the company to regain compliance with the minimum closing bid price rule. If compliance is not met by that date, Nasdaq may initiate delisting procedures. The company specializes in healthcare solutions for brachytherapy treatment planning…

LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer

LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer

LeonaBio, a clinical-stage biopharmaceutical company, announced a virtual Key Opinion Leader event focused on lasofoxifene, its investigational therapy for treatment-resistant estrogen receptor-positive, HER2-negative, ESR1-mutated metastatic breast cancer. The company expects to complete enrollment in its Phase 3 ELAINE-3 study by late 2026 and an…

Trevi Therapeutics to Participate in Upcoming May Events

Trevi Therapeutics to Participate in Upcoming May Events

Trevi Therapeutics, a clinical-stage biotech company, announced participation in multiple investor and analyst events in May 2026 to showcase its investigational treatment, Haduvio™, for chronic cough associated with idiopathic pulmonary fibrosis, non-IPF interstitial lung disease, and refractory chronic cough. The company will provide data present…